Oculus Innovative Sciences represents a good buy for value investors or cash-rich companies such as Allergan.
Here are Wednesday's top research calls, including upgrades of CSX and LinkedIn.
Occulus Innovative Sciences (OCLS) shares are up double digits after the company announced a new U.S. patent for its Microcyn Technology hypoclorous acid.
Trade-Ideas LLC identified Oculus Innovative (OCLS) as a strong on high relative volume candidate
Oculus Innovative Sciences (OCLS) shares are gaining after the company beat analysts' fourth quarter earnings and revenue expectations.